NCT05068206 2021-10-20
A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOx
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2 Unknown